Loading...
A Comprehensive Review of US FDA-Approved Immune Checkpoint Inhibitors in Urothelial Carcinoma
Few effective treatment options are available for patients with advanced or metastatic urothelial carcinoma (UC) after unsuccessful first-line platinum-based chemotherapy. To date, immune checkpoint inhibitors are novel therapeutic agents for UC treatment. From May 2016 to May 2017, five anti-PD-1/P...
Na minha lista:
| Udgivet i: | J Immunol Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5742464/ https://ncbi.nlm.nih.gov/pubmed/29376081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/6940546 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|